12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Arzerra ofatumumab regulatory update

Genmab and GlaxoSmithKline said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Arzerra ofatumumab to treat relapsed...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >